The people who have sold Visa tend to be really stupid. Now, I don't know how they did in their SATs or what schools they got into. It doesn't really matter.But I do think that this is another great quarter from Visa. Well, that was Jim Kramer earlier this morning after the report. Stock is up 1%.Where'd you go to school. We all Jim Leventhal sold you sold Visa. Yeah. Yeah.You didn't just trim Visa, you sold Visa. Yeah. Um why did you do that.Uh let me just start by saying there's no forever stock. Okay. Do ...

You know, I think if there were a beauty contest for GDP releases that Miss July would probably be very close to the top of the list of the early betting because it got everything for everybody. There's really strong growth, really strong income growth. We've got a huge reduction in government spending, 5% drop in government spending, now 70,000 fewer federal employees.Uh, and we've got 127 billion in tariffs. And so the story, the anti-Trump story has been that we're going to have a recession or a depressi ...

band. Emily Wilkins live in DC. Want to move on to a company reporting its earnings after the bell today.That's Meta. It CEO Mark Zuckerberg laying out his new vision for personal super intelligence and a social post. Again, that's ahead of Meta reporting his earnings later.Set to be a key read on the digital ad business and amid both AI uh potential and some economic uncertainty. Julia Borston has much more on what to expect in today's tech check. Julia.Well, Frank, Meta shares aren't moving today on Zucke ...

Speaking about hoarding cash, how about hoarding stable coins. I know you have some thoughts here. We saw the Genius Act packact.We've seen the enthusiasm in names like Circle and and it feels like we are on the brink of some sort of systemic change. What do you what do you make of all of it. >> So, look, I understand the allure of a stable coin. I understand the allure of having a digital currency that you can move very freely with no transaction cost.That to me is is is is an important piece of the equati ...

Some news in Washington. Emily Wilkins with a news alert from Congress. Emily.Hey Sarah. Well, a Senate panel just approved legislation that would ban members of Congress, the president and the vice president from selling and trading stocks. Now, this has advanced through a Senate committee uh with all Democratic support and all but one Republican, Senator Josh Holly, opposed the bill.So, Holly and the Democrats moved to pass it. However, strong Republican opposition means it might not really stand a chance ...

Money Mover is getting set for Ambic to make its trading debut here at the New York Stock Exchange. After raising 96 million in its IPO, this company specializes in ultra- low power semiconductors for AI across end markets like healthcare, industrial, automation, and wearable devices. One of several high-profile tech names to go public in recent weeks.And joining us right here at Post 9, we have Ambic CEO Umei Asaka. Um, thanks for joining us. >> Thank you for having me.>> All right, we were just talking du ...

Financial Performance - Teva Pharmaceuticals reported an earnings beat in Q2 and raised revenue guidance for the year end [1] - Teva's innovative drugs grew by 27% this quarter [3] - AJOVY grew at 31%, AUSTEDO is up 120%, and AJOVY is up 22% in the US [7] - AUSTEDO is expected to achieve $2 billion in sales this year and is growing at 22% in the US [9] - The company is focused on paying down debt, growing the top line, and increasing profitability to achieve investment grade [11][12] - Earnings per share are up [12] Market Dynamics and Pipeline - Tariffs could put pressure on drug makers and their manufacturing overseas [1] - Approximately 43% of branded drugs sold in the US come from Europe, and about 18% of generics [2] - Teva has limited exposure to tariffs emerging from China and India due to its supply chain [4] - Teva is transforming from a pure play generics player to a biopharma player [13] - Teva plans to file lanzipene with the FDA towards the end of this year, bring a treatment for asthma to market in 2027, and a treatment for oscillitis and Crohn's disease to market in 2028-2029 [15]

Given all of the value offerings right now across the restaurant sector, quite frankly, uh, within coffee, Lucken is now offering $2 ice coffees and lattes. Why is hospitality the answer to the challenges that Starbucks is facing right now. Look, we have 7,700 drive-throughs in America.We've got a a digital business, which is 31% which is doing really healthy. We we have the third place. We going to get ready to go into Uplifts, which will start to remodel and bring the comfort back into the experience.That ...

Welcome back to Money Movers. Take a look at Robin Hood. It shares have surged 400% over the past year.So, what could be the next growth driver for the company. Our Mackenzie Sagalos is looking into that ahead of earnings this afternoon. McKenzie, >> hey Frank.So, Robin Hood heads into earnings on one of Wall Street's hottest streaks. Shares are up 177% this year after nearly doubling in 2024, pushing its market cap past $90 billion and making it the top performing large cap US tech stock. Now despite that ...

Welcome back. Shares of Manderly are under pressure this morning. Despite the company beating earnings and revenue estimates while the company reiterated guidance, it does include a 10% hit to EPS due to cocoa cost inflation.Organic growth and gross margins also falling short of expectations. Joining us in an exclusive interview is Manderly's chairman and CEO Dirk Bandut. How would these results and h how would the environment be different if we didn't have this crazy cocoa price inflation.>> Well, it it wo ...